Keyword: Q3 2012

News

Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

02.11.2012 - Vertex Pharmaceuticals reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its...

News

Teva Pharmaceutical Adjusted Profit Tops Estimates

01.11.2012 - Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...

News

Rosneft's $5.8 Billion Q3 Net Profit Beats Borecasts

01.11.2012 - Higher oil prices and lower taxes fuelled Rosneft to a 181 billion roubles ($5.8 billion) net income in the third-quarter, the company said on Thursday. Analysts polled by Reuters...

News

Pfizer Quarterly Revenue Fall Far Short of Forecasts

01.11.2012 - Pfizer reported on Thursday quarterly revenue well below Wall Street expectations, on sharply weaker sales of specialty care drugs and a pullback of emerging market revenue...

News

Refining Underpins Shell Q3 as Output Stalls

01.11.2012 - World No. 2 oil company Royal Dutch Shell, seen as having some of the best output growth assets in the business, joined its peers in suffering lower production in the third quarter...

News

Norway's Orkla Beats Forecasts with Q3 Profit

31.10.2012 - Norwegian food and industrial conglomerate Orkla reported third-quarter earnings above forecasts on Wednesday and predicted margin pressures in its vital grocery business. Orkla...

News

Clariant Profit Weakens with World Economy

31.10.2012 - Swiss speciality chemicals maker Clariant reported a larger-than-expected fall in net income for the third quarter, hit by fresh deterioration in the global economy. Clariant...

News

Switzerland's Lonza to Cut 500 Jobs

31.10.2012 - Swiss drugs industry supplier Lonza plans to cut 500 jobs, including 400 at its main plant in Visp, to improve profitability as it grapples with price pressures, a strong Swiss...